As with every other integration, who stays or goes will ultimately be determined by geography, market access, etc. Between the cardiovascular and women's health divisions, Pfizer has around 800 reps in the field calling on primary care customers nationwide. There are some geographical holes, particularly in the Midwest and Northwest, which were purposely created with the January 2022 realignment. Those areas are exclusively covered by the call center. The effectiveness of that coverage is up for debate.
